Next |
home / stock / cyad / cyad message board
Subject | By | Source | When |
---|---|---|---|
Good time to buy | harry crumb | investorshub | 02/25/2023 10:30:10 AM |
Better be buying, itl rip again anytime | harry crumb | investorshub | 02/16/2023 2:04:11 AM |
znewcar1: $CYAD 32% v14,3M c1.50 f22,593M H1.85 ML.62 RL1.11 LL.46 | znewcar1 | investorshangout | 02/07/2023 10:55:26 PM |
Dip for the rip!!! | Jess070283 | investorshub | 02/07/2023 3:44:03 PM |
Looks good Im in $$$$$ | INFINITI | investorshub | 02/07/2023 3:25:14 PM |
1.60 on light vol | TheFinalCD | investorshub | 02/07/2023 11:04:45 AM |
Action going on again | harry crumb | investorshub | 02/07/2023 10:53:56 AM |
Outlook is not real promising | harry crumb | investorshub | 02/03/2023 1:14:29 PM |
Frightening chart it is | harry crumb | investorshub | 01/27/2023 10:18:29 PM |
What happened to this | harry crumb | investorshub | 01/25/2023 6:08:54 AM |
She is clawing back towards GREEN after $1.91 | subslover | investorshub | 01/19/2023 7:06:33 PM |
znewcar1: $CYAD 24% v20,1M c2.37 f22,594M H3.07 ML.46 YL1.13 morning >2 to Hod | znewcar1 | investorshangout | 01/18/2023 11:08:09 PM |
nice day almost $3 $CYAD | TheFinalCD | investorshub | 01/18/2023 7:55:48 PM |
znewcar1: $CYAD hod2.98 Held 1.6 off yesterday pop BO2.22 to hod | znewcar1 | investorshangout | 01/18/2023 7:53:53 PM |
znewcar1: $CYAD 137% v65,2M c1.90 f22,593M H2.50 S>1.6? | znewcar1 | investorshangout | 01/17/2023 9:34:01 PM |
Yes halted! Winner $$$$$ buy buy buy | harry crumb | investorshub | 01/17/2023 2:56:38 PM |
$CYAD halted UP^^^ | TheFinalCD | investorshub | 01/17/2023 2:52:58 PM |
WILD $RIDE 1.20-.170 nice pop | TheFinalCD | investorshub | 01/17/2023 2:47:15 PM |
https://finviz.com/quote.ashx?t=$CYAD&ty=c&ta=1&p=d | TheFinalCD | investorshub | 01/17/2023 12:46:22 PM |
You predicted it back on 8-1-22. Good catch. | Dragon firefly | investorshub | 01/17/2023 11:28:39 AM |
News, Short Squeeze, Breakout and More Instantly...
Celyad SA Company Name:
CYAD Stock Symbol:
NASDAQ Market:
MONT-SAINT-GUIBERT, Belgium, May 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), is a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies. The Company had previously announced...
MONT-SAINT-GUIBERT, Belgium, April 24, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, received a letter (the “Bid Price No...
MONT-SAINT-GUIBERT, Belgium, April 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, received a letter (the “Letterȁ...